"Ochsner Medical Center - Baton Rouge offers 24-hour emergency care, a Family Birthing Center and advanced specialty care."

During the past decade, Baton Rouge General Medical Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 45 clinical trials were completed, i.e. on average, 77.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 25 clinical trials were completed. i.e. 192.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baton Rouge General Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 54 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SCRI Development Innovations, LLC" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baton Rouge General Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 4 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Baton Rouge General Medical Center" are "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Stage IV Lung Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Baton Rouge General Medical Center" in a lesser frequency.

Most popular intervention types in "Baton Rouge General Medical Center" are "Drug" (97 trials), "Other" (64 trials), "Biological" (45 trials), "Procedure" (28 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (24 trials), "Biospecimen Collection" (14 trials), "Carboplatin" (14 trials) and "Bevacizumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Baton Rouge General Medical Center" are 105 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Baton Rouge General Medical Center". undefined are not yet recruiting, 18 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Baton Rouge General Medical Center, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Baton Rouge General Medical Center, 1 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Baton Rouge General Medical Center has several departments that took part in Clinical trials: "Louisiana Hematology Oncology Associates LLC" - 82 trials, "Pennington Cancer Center at Baton Rouge General" - 28 trials